Healthcare provider profile · identity verified

Erik Carpio, MD

Family Practice · AUBURN, CA · NPI 1396236907

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	601	179
Levothyroxine Sodium	Levothyroxine Sodium	386	95
Losartan Potassium	Losartan Potassium	344	104
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	279	66
Lisinopril	Lisinopril	247	69
Amlodipine Besylate	Amlodipine Besylate	208	66
Trazodone Hcl	Trazodone Hcl	182	62
Tamsulosin Hcl	Tamsulosin Hcl	175	51
Pantoprazole Sodium	Pantoprazole Sodium	164	48
Omeprazole	Omeprazole	159	57
Gabapentin	Gabapentin	152	46
Hydrochlorothiazide	Hydrochlorothiazide	146	43
Simvastatin	Simvastatin	132	34
Zolpidem Tartrate	Zolpidem Tartrate	121	28
Metoprolol Succinate	Metoprolol Succinate	111	35
Atenolol	Atenolol	103	27
Albuterol Sulfate Hfa	Albuterol Sulfate	97	45
Metformin Hcl	Metformin Hcl	96	29
Escitalopram Oxalate	Escitalopram Oxalate	91	27
Fluticasone Propionate	Fluticasone Propionate	84	34
Fluoxetine Hcl	Fluoxetine Hcl	82	21
Metformin Hcl Er	Metformin Hcl	80	27
Sertraline Hcl	Sertraline Hcl	80	24
Eliquis	Apixaban	74	19
Metoprolol Tartrate	Metoprolol Tartrate	72	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	19
Ozempic	Semaglutide	70	14
Rosuvastatin Calcium	Rosuvastatin Calcium	64	21
Allopurinol	Allopurinol	63	18
Buprenorphine Hcl	Buprenorphine Hcl	62	11
Furosemide	Furosemide	62	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	22
Bupropion Xl	Bupropion Hcl	59	21
Pravastatin Sodium	Pravastatin Sodium	59	15
Cephalexin	Cephalexin	58	46
Finasteride	Finasteride	58	18
Montelukast Sodium	Montelukast Sodium	57	18
Potassium Chloride	Potassium Chloride	55	18
Tramadol Hcl	Tramadol Hcl	54	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	13
Famotidine	Famotidine	51	16
Estradiol	Estradiol	50	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	50	18
Ibuprofen	Ibuprofen	49	23
Alendronate Sodium	Alendronate Sodium	48	17
Duloxetine Hcl	Duloxetine Hcl	47	16
Sumatriptan Succinate	Sumatriptan Succinate	45	suppressed
Clonazepam	Clonazepam	41	suppressed
Meloxicam	Meloxicam	40	16
Acyclovir	Acyclovir	39	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	14
Lorazepam	Lorazepam	38	16
Mirtazapine	Mirtazapine	37	13
Lovastatin	Lovastatin	36	suppressed
Glipizide	Glipizide	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	29
Carvedilol	Carvedilol	34	11
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	12
Spironolactone	Spironolactone	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	13
Pregabalin	Pregabalin	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Alprazolam	Alprazolam	29	13
Hydroxyzine Hcl	Hydroxyzine Hcl	29	12
Triamcinolone Acetonide	Triamcinolone Acetonide	29	20
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Prednisone	Prednisone	28	20
Trulicity	Dulaglutide	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	15
Baclofen	Baclofen	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Diazepam	Diazepam	26	14
Jardiance	Empagliflozin	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Azithromycin	Azithromycin	25	25
Benazepril Hcl	Benazepril Hcl	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	11
Terazosin Hcl	Terazosin Hcl	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Dexlansoprazole Dr	Dexlansoprazole	21	suppressed
Valsartan	Valsartan	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Temazepam	Temazepam	20	suppressed
Topiramate	Topiramate	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Naproxen	Naproxen	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Progesterone	Progesterone, Micronized	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Risperidone	Risperidone	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error